Clonazepam (Epilepsy) updated on 02-10-2025

Child/Infant death (> 28 days of life)

R analysis
id Study   Lib. in paper Exposition period    Study type 
 Control type 
 
Tags OR 95%CI x1/n1 x0/n0 no cases no exposed ROB Ref.
S5924
R15063		 Artama (Epilepsy) (Controls exposed to Lamotrigine, sick), 2013 Infant death (0–364 days of age) during pregnancy (anytime or not specified) population based cohort retrospective exposed to other treatment, sick excluded Adjustment: No 4.23 [0.16;109.02] C
excluded (control group) 		0/14   1/173 1 14
ref
S5905
R14855		 Artama (Epilepsy) (Controls unexposed, disease free), 2013 Infant death (0–364 days of age) during pregnancy (anytime or not specified) population based cohort retrospective unexposed, disease free excluded Adjustment: No 12.97 [0.77;218.29] C
excluded (control group) 		0/14   2,048/719,509 2,048 14
ref
S5916
R14974		 Artama (Epilepsy) (Controls unexposed, sick), 2013 Infant death (0–364 days of age) during pregnancy (anytime or not specified) population based cohort retrospective unexposed, sick Adjustment: No 12.04 [0.63;228.65] C 0/14   5/1,793 5 14
ref
Total 1 studies 12.04 [0.63;228.65] 5 14
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives

Forest plot

StudyTE95% CIn casesn exposedweightROBABCDEF Artama (Epilepsy) (Controls unexposed, sick), 2013Artama, 2013 1 12.04[0.63; 228.65]5140%ROB confusion: criticalROB selection: lowROB classification: criticalROB missing: lowROB mesure: moderateROB reporting: moderate0.950.01.0ROB: A: confusion, B: selection, C: classification, D: missing, E: measurement, F: reportinglow,moderate,serious,critical,unclear,

1: Epilepsy) (Controls unexposed, sick;

Sensitivity analysis

SubsetTE95% CIn casesn exposedkI2 Type of studies cohort studiescohort studies 12.04[0.63; 228.65]514 -NAArtama (Epilepsy) (Controls unexposed, sick), 2013 1 case control studiescase control studies 0 Type of controls unexposed, sickunexposed, sick 12.04[0.63; 228.65]514 -NAArtama (Epilepsy) (Controls unexposed, sick), 2013 1 Tags Adjustment   - No  - No 12.04[0.63; 228.65]514 -NAArtama (Epilepsy) (Controls unexposed, sick), 2013 1 All studiesAll studies 12.04[0.63; 228.65]514 -NAArtama (Epilepsy) (Controls unexposed, sick), 2013 10.550.01.0

Publication bias and p-hacking diagnosis

funnel plot

Funnel plot not drawn. Less than 3 points.

Asymetry test p-value = NaN (by Egger's regression)

not enought points

p values plot

Funnel plot not drawn. Less than 3 points.

Sub-groups analysis using all included studies

excluded 5924, 5905

Sub-groupsTE95% CIn casesn exposedkI2ROB type of controls unexposed controls (disease free or unspecified)unexposed controls (disease free or unspecified) Out of scale12.97[0.77; 218.29]2,04814 -NAArtama (Epilepsy) (Controls unexposed, disease free), 2013 1 unexposed, sick controlsunexposed, sick controls Out of scale12.04[0.63; 228.65]514 -NAArtama (Epilepsy) (Controls unexposed, sick), 2013 1 exposed to other treatment, sick controlsexposed to other treatment, sick controls 4.23[0.16; 109.02]114 -NAArtama (Epilepsy) (Controls exposed to Lamotrigine, sick), 2013 10.510.01.0